Beleggen.nl Markt MonitorMarkt Monitor

Amerikaanse aandelen Terug naar discussie overzicht

Cannabis aandelen

8.267 Posts
Pagina: «« 1 ... 339 340 341 342 343 ... 414 »» | Laatste | Omlaag ↓
  1. forum rang 10 DeZwarteRidder 9 november 2019 11:24
    quote:

    Empros schreef op 9 november 2019 11:20:

    Wtf...! Aangedikt met vitamine E?
    Go and report yourself!
    Je kunt dat prima opeten, maar als damp in je longen is het heel slecht.

    Hetzelfde geldt trouwens voor asbest.
  2. Empros 9 november 2019 11:58
    Baaidewee...Op zoek naar diversificatie van je porto? Hou Alibaba (BABA) in het oog ...listing HongKong 25/11!
    Good hunting
  3. Rider 12 november 2019 09:23
    quote:

    DeZwarteRidder schreef op 12 november 2019 00:15:

    [...]
    De verwachtingen zijn duidelijk te hoog.
    Alefia staat nog zeer goedkoop tegenover andere cannabisaandelen.
  4. Rider 12 november 2019 09:33
    quote:

    Osho schreef op 12 november 2019 09:15:

    Cijfers Organigram vallen tegen.
    547% meer dan in 2018 en het is nog niet goed. Mensen snappen niet dat dit een nieuwe markt is.
  5. [verwijderd] 12 november 2019 13:19
    quote:

    Rider schreef op 12 november 2019 09:33:

    [...]

    547% meer dan in 2018 en het is nog niet goed. Mensen snappen niet dat dit een nieuwe markt is.
    OGI premarket -18%. Denk dat ik nog wat ga bijkopen dan.
  6. Jezzaa 12 november 2019 13:25
    Organigram Holdings Inc. issued revenue guidance late Monday, saying that it now expects fiscal fourth-quarter net revenue of C$16.3 million ($12.3 million), a sequential decline from third-quarter revenue of C$24.8 million. Analysts polled by FactSet had expected fourth-quarter revenue of C$27.9 million. U.S. traded shares of Organigram fell more than 11% in the extended session. Organigram's fiscal fourth quarter ended in August and the revenue estimate is net of excise taxes. Organigram said it shipped about $20 million worth of cannabis during the quarter and said the lack of retail stores was partly to blame. The company said it expects to have roughly $47.9 million in cash and equivalents by the end of the quarter. "While Q4 2019 did not meet our overall expectations, we have not only emerged as one of the national leaders in the industry with significant growth expected in net revenue and strong market share, we expect to report positive adjusted EBITDA for the year," Chief Executive Greg Engel said in a statement. The company will report earnings in full Nov. 25 before the market opens and has a conference call scheduled for 8:00 a.m. Eastern time.

8.267 Posts
Pagina: «« 1 ... 339 340 341 342 343 ... 414 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beleggen.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.016
AB InBev 2 5.495
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.608
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 264
Accsys Technologies 23 10.612
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 188
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.747
Aedifica 3 908
Aegon 3.258 322.708
AFC Ajax 538 7.088
Affimed NV 2 6.296
ageas 5.844 109.891
Agfa-Gevaert 14 2.049
Ahold 3.538 74.331
Air France - KLM 1.025 35.034
AIRBUS 1 11
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.036
Alfen 16 24.769
Allfunds Group 4 1.470
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 406
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.822
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.836 243.003
AMG 971 133.250
AMS 3 73
Amsterdam Commodities 305 6.689
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 491
Antonov 22.632 153.605
Aperam 92 14.994
Apollo Alternative Assets 1 17
Apple 5 381
Arcadis 252 8.772
Arcelor Mittal 2.033 320.686
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.300
Aroundtown SA 1 219
Arrowhead Research 5 9.731
Ascencio 1 26
ASIT biotech 2 697
ASMI 4.108 39.093
ASML 1.766 106.794
ASR Nederland 21 4.469
ATAI Life Sciences 1 7
Atenor Group 1 485
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.661
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.392